Glioblastoma: all 1,951 studies
Page 18 of 20. Open to participants first (457), then studies with results posted, then the rest; newest registration first within each.
- Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical ResectionCompletedNCT01006044Phase 2
- A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)TerminatedNCT00990496Phase 1
- Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma MultiformeWithdrawnNCT00984438Phase 1/2
- Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent GlioblastomaCompletedNCT00979862Phase 1
- Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00974987Phase 2
- The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary FunctionCompletedNCT00973557
- Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)CompletedNCT00968240Phase 1
- Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During SurgeryCompletedNCT00961090Phase 2
- Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With GlioblastomaCompletedNCT00960492Phase 1
- ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsCompletedNCT00946335Phase 1
- Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed GlioblastomaCompletedNCT00944801Phase 1/2
- Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBMWithdrawnNCT00943462
- Comparison of Standard Neuronavigation With Intraoperative Magnetic Resonance Imaging (MRI) for the Neurosurgical Treatment of Malignant Brain TumorsCompletedNCT00943007Not applicable
- Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent GlioblastomaCompletedNCT00941460Phase 2
- Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed GlioblastomaStatus unknownNCT00936052Phase 2
- A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent GliomasCompletedNCT00921167Phase 2
- Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma MultiformeCompletedNCT00919737Phase 1/2
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)CompletedNCT00916409Phase 3
- Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma MultiformeTerminatedNCT00915694Phase 1
- Evaluation of [18F]-FMISO for Non Operated GlioblastomaCompletedNCT00906893Phase 2
- Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma MultiformeStatus unknownNCT00906516Phase 2
- Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma MultiformeWithdrawnNCT00904852Phase 1
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor TherapiesCompletedNCT00897663
- Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed GlioblastomaTerminatedNCT00895960Phase 1
- Phase 2 Study MPC-6827 for Recurrent Glioblastoma MultiformeCompletedNCT00892931Phase 2
- Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma MultiformeCompletedNCT00890032Phase 1
- Sorafenib in Newly Diagnosed High Grade GliomaCompletedNCT00884416Phase 1
- Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma MultiformeCompletedNCT00883298Phase 2
- ADV-TK Improves Outcome of Recurrent High-Grade GliomaCompletedNCT00870181Phase 2
- Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent GlioblastomaCompletedNCT00864864Early Phase 1
- Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in GlioblastomaCompletedNCT00846456Phase 1/2
- Vandetanib and Sirolimus in Patients With Recurrent GlioblastomaCompletedNCT00821080Phase 1
- Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma MultiformeCompletedNCT00820963Phase 3
- Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)CompletedNCT00817284Phase 2
- Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by SurgeryWithdrawnNCT00814593Phase 2
- A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma MultiformeCompletedNCT00800917Phase 2
- Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)WithdrawnNCT00797940Phase 2
- A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed GlioblastomaCompletedNCT00792012Phase 1
- Borderzone SamplingCompletedNCT00780819Not applicable
- Measuring Non-Enhancing Glioblastoma ProgressionCompletedNCT00777686
- ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00770471Phase 1
- CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT00768911Phase 1
- A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent GlioblastomaCompletedNCT00762255Phase 1
- Nimotuzumab in Adults With Glioblastoma MultiformaCompletedNCT00753246Phase 3
- Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant GliomasCompletedNCT00751270Phase 1
- Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain TumorsCompletedNCT00747253Phase 1
- Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant GliomaWithdrawnNCT00734864Phase 1
- A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade GliomasCompletedNCT00734682Phase 1
- Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or GliosarcomaTerminatedNCT00734526Phase 1
- Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant GliomaCompletedNCT00730613Phase 1
- Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma MultiformeTerminatedNCT00730262Phase 2
- Patupilone (EPO 906) in Patients With Recurrent or Progressive GlioblastomaCompletedNCT00715013Phase 1/2
- A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant GliomasCompletedNCT00704080Phase 1
- Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed GlioblastomaWithdrawnNCT00703859Phase 1
- Study With Nelfinavir and Combined Radiochemotherapy for GlioblastomaCompletedNCT00694837Phase 1
- Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive TransferCompletedNCT00693095Phase 1
- Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant GliomaCompletedNCT00687765Phase 1/2
- Establishment of a Brain and Spinal Tumor Tissue BankStatus unknownNCT00686387
- A Study of 131I-TM601 in Adults With Recurrent Malignant GliomaStatus unknownNCT00683761Phase 1/2
- Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First RelapseCompletedNCT00677716Phase 2
- Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase ITerminatedNCT00671801Phase 1
- Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT00662506Phase 1/2
- Efficacy Study of CYT997 in Combination With Carboplatin in GlioblastomaTerminatedNCT00650949Phase 1/2
- Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant GliomaCompletedNCT00650923Phase 1
- Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.WithdrawnNCT00645385
- Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma PatientsStatus unknownNCT00643825Phase 2
- Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00639639Phase 1
- Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma MultiformeStatus unknownNCT00635557Phase 1/2
- Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused LymphopeniaCompletedNCT00626483Phase 1
- Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by SurgeryCompletedNCT00626015Phase 1
- Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)CompletedNCT00624728Phase 1/2
- Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + TemozolomideCompletedNCT00616005Phase 2
- Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody TherapyTerminatedNCT00615186Phase 3
- Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant GliomasCompletedNCT00613223Phase 1
- Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MGCompletedNCT00613132Phase 1
- Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant GliomaCompletedNCT00613093Phase 2
- Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant GliomaCompletedNCT00613054Phase 1
- Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBMCompletedNCT00612989Phase 1
- PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant GliomasCompletedNCT00612651Phase 1
- Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic GliomasCompletedNCT00612638Phase 1
- Ph I SU011248 + Irinotecan in Treatment of Pts w MGCompletedNCT00611728Phase 1
- Ph I Oral Topotecan and Temozolomide for Patients With Malignant GliomasCompletedNCT00610571Phase 1
- Ph I Dasatinib + Erlotinib in Recurrent MGCompletedNCT00609999Phase 1
- Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant GliomaStatus unknownNCT00591058Phase 1
- Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance ModalitiesTerminatedNCT00589095
- A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma MultiformeCompletedNCT00584883Phase 1
- Immunotherapy for Patients With Brain Stem Glioma and GlioblastomaCompletedNCT00576641Phase 1
- Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain TumorsCompletedNCT00576537Phase 2
- Gliadel Wafers and Temodar in the Treatment of Glioblastoma MultiformeTerminatedNCT00574964Phase 2
- CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With IrinotecanStatus unknownNCT00562419Phase 2
- Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBMTerminatedNCT00548938Phase 2
- The Safety and Efficacy of DCA for the Treatment of Brain CancerCompletedNCT00540176Phase 2
- SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma MultiformeStatus unknownNCT00535379Phase 2
- Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent GlioblastomaStatus unknownNCT00521482Phase 2
- Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma MultiformeCompletedNCT00509301Phase 1
- Dietary Methionine Restriction Plus Temozolomide for Recurrent GBMTerminatedNCT00508456Phase 1
- Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain TumourCompletedNCT00503204Phase 1
- Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant GliomasStatus unknownNCT00492687Phase 2
- Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)CompletedNCT00481455Phase 2
- The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade AstrocytomasTerminatedNCT00473408